Category: Reports

Our Inaugural Sustainability Report 2021/2022

The Upside – EDBI E-Newsletter 2022 Q3

Presenting new developments in Q3

The Upside – EDBI E-Newsletter 2022 Q2

We continue to focus on value creation efforts for our portfolio companies.

Enhancing the development of the ASEAN markets and accelerating global market expansion for Chinese biopharma companies

Take a deep dive into the ASEAN biopharmaceutical landscape